Laboratory-induced cue reactivity among individuals with prescription opioid dependence

Addictive Behaviors

Volumn 39, Issue 8, 2014, Pages 1217-1223

  Back, Sudie E ^a,b   Gros, Daniel F ^a,b   McCauley, Jenna L ^a   Flanagan, Julianne C ^a   Cox, Elizabeth ^c   Barth, Kelly S ^a   Brady, Kathleen T ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Drug cue paradigm; Drug cue reactivity; Opiates; Prescription drugs; Prescription opioids

Indexed keywords

HYDROCORTISONE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; ANGER; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CUE REACTIVITY PARADIGM; FEMALE; HEART RATE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LABORATORY TEST; MALE; OPIATE ADDICTION; PRESCRIPTION; PRESCRIPTION OPIOID DEPENDENCE; SKIN CONDUCTANCE; STRESS; WITHDRAWAL SYNDROME; ADDICTION; ASSOCIATION; CASE CONTROL STUDY; CHEMISTRY; ELECTRODERMAL RESPONSE; EMOTION; MENTAL STRESS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; SALIVA; YOUNG ADULT;

ADULT; BEHAVIOR, ADDICTIVE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CRAVING; CUES; EMOTIONS; FEMALE; GALVANIC SKIN RESPONSE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; QUESTIONNAIRES; SALIVA; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84900316924     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2014.04.007     Document Type: Article

References (67)

1. Adams S., Munafo M.R. Will peak provoked craving prove superior to cue-reactivity?. Addiction 2013, 108:1027-1028.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (4th ed. text revision) 2000, American Psychiatric Association, Washington DC.
3. Back S.E., Hartwell K., DeSantis S.M., Saladin M., McRae-Clark A.L., Price K.L., et al. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug and Alcohol Dependence 2010, 106:21-27.
4. Back S.E., Lawson K., Singleton L., Brady K.T. Characteristics and correlates of men and women with prescription opioid dependence. Addictive Behaviors 2011, 36:829-834.
5. Bagot K.S., Heishman S.J., Moolchan E.T. Tobacco craving predicts lapse to smoking among adolescent smokers in cessation treatment. Nicotine & Tobacco Research 2007, 9:647-652.
6. Barth K.S., Back S.E., Moran-Santa Maria M., Lawson K., Shaftman S., Brady K.T. Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence. American Journal on Addictions 2013, 22:486-491.
7. Behera D., Goswami U., Khastgir U., Kumar S. Craving by imagery cue reactivity in opiate dependence following detoxification. Indian Journal of Psychiatry 2003, 45:178-181.
8. Carroll K.M., Ball S.A., Nich C., O'Connor P.G., Eagan D.A., Frankforter T.L., et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Archives of General Psychiatry 2001, 58:755.
9. Carter B.L., Tiffany S.T. Meta-analysis of cue-reactivity in addiction research. Addiction 1999, 94(3):327-340.
10. Carter B.L., Tiffany S.T. Cue-reactivity and the future of addiction research. Addiction 1999, 94(3):349-351.
11. Childress A., Ehrman R., McLellan A.T., O'Brien C. Conditioned craving and arousal in cocaine addiction: A preliminary report. NIDA Research Monograph Index 1988, 81:74-80.
12. Childress A.R., McLellan A.T., O'Brien C.P. Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. British Journal of Addiction 1986, 81(5):655-660.
13. Childress A.R., McLellan A.T., O'Brien C.P. Conditioned responses in a methadone population: A comparison of laboratory, clinic, and natural settings. Journal of Substance Abuse Treatment 1986, 3(3):173-179.
14. Conklin C.A. Environments as cues to smoke: Implications for human extinction-based research and treatment. Experimental and Clinical Psychopharmacology 2006, 14:12.
15. Conklin C.A., Parzynski C.S., Salkeld R.P., Perkins K.A., Fonte C.A. Cue reactivity as a predictor of successful abstinence initiation among adult smokers. Experimental Clinical Psychopharmacology 2012, 20:473-478.
16. Cunningham K.A., Anastasio N.C. Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology 2014, 76:460-478.
17. Cuthbert B.N., Bradley M.M., Lang P.J. Probing picture perception: Attention and emotion. Psychophysiology 1996, 33:103-111.
18. Daglish M.R., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Britten S., et al. Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. American Journal of Psychiatry 2001, 158(10):1680-1686.
19. Dhalla I.A., Persaud N., Juurlink D.N. Facing up to the prescription opioid crisis. BMJ 2011, 343.
20. Drobes D.J. Cue reactivity in alcohol and tobacco dependence. Alcoholism: Clinical and Experimental Research 2002, 26(12):1928-1929.
21. Drummond D.C. What does cue-reactivity have to offer clinical research?. Addiction 2000, 95:129-144.
22. Engelmann J.M., Versace F., Robinson J.D., Minnix J.A., Lam C.Y., Cui Y., et al. Neural substrates of smoking cue reactivity: A meta-analysis of fMRI studies. Neuroimaging 2012, 60:252-262.
23. Fatseas M., Denis C., Massida Z., Verger M., Franques-Reneric P., Auriacombe M. Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biological Psychiatry 2011, 70:720-727.
24. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders 2002, New York State Psychiatric Institute, Biometrics Research, New York.
25. Fischer B., Nakamura N., Rush B., Rehm J., Urbanoski K. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug and Alcohol Dependence 2010, 109:257-260.
26. Franken I.H., de Haan H.A., van der Meer C.W., Haffmans P.M., Hendriks V.M. Cue reactivity and effects of cue exposure in abstinent posttreatment drug users. Journal of Substance Abuse Treatment 1999, 16:81-85.
27. Garland E.L., Carter K., Ropes K., Howard M.O. Thought suppression, impaired regulation of urges, and Addiction-Stroop predict affect-modulated cue-reactivity among alcohol dependent adults. Biological Psychology 2012, 89:87-93.
28. Haug N.A., Sorensen J.L., Gruber V.A., Song Y.S. Relapse prevention for opioid dependence. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors 2005, 151-178. Guilford Pres, New York, NY. 2nd ed. G.A. Marlatt, D.M. Donovan (Eds.).
29. Hendershot C.S., Witkiewitz K., George W.H., Marlatt G.A. Relapse prevention for addictive behaviors. Substance Abuse Treatment, Prevention, and Policy 2011, 6:1-17.
30. Joranson D.E., Gilson A.M., Dahl J.L., Haddox J.D. Pain management, controlled substances, and state medical board policy: A decade of change. Journal of Pain Symptom Management 2002, 23:138-147.
31. Joranson D.E., Ryan K.M., Gilson A.M., Dahl J.L. Trends in medical use and abuse of opioid analgesics. JAMA 2000, 283:1710-1714.
32. Katz N.P., Adams E.H., Chilcoat H., Colucci R.D., Comer S.D., Goliber P., et al. Challenges in the development of prescription opioid abuse-deterrent formulations. The Clinical Journal of Pain 2007, 23:648-660.
33. Lang P.J., Ohman A., Vaitl D. The International Affective Picture System [photographic slides] 1988, The Center for Research in Psychophysiology, University of Florida, Gainesville, FL.
34. Li Q., Wang Y., Zhang Y., Li W., Yang W., Zhu J., et al. Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: An event-related fMRI study. Brain Research 2012, 1469:63-72.
35. Lou M., Wang E., Shen Y., Wang J. Cue-elicited craving in heroin addicts at different abstinent time: An fMRI pilot study. Substance Use and Misuse 2012, 47:631-639.
36. Mainz V., Druke B., Boecker M., Kessel R., Gauggel S., Forkmann T. Influence of cue exposure on inhibitory control and brain activation in patients with alcohol dependence. Frontiers in Human Neuroscience 2012, 6:92.
37. McLellan A.T., Cacciola J.C., Alterman A.I., Rikoon S.H., Carise D. The Addiction Severity Index at 25: Origins, contributions and transitions. American Journal of Addictions 2006, 15:113-124.
38. Modesto-Lowe V., Kranzler H.R. Using cue reactivity to evaluate medications for treatment of cocaine dependence: A critical review. Addiction 1999, 94:1639-1651.
39. Niaura R.S., Rohsenow D.J., Binkoff J.A., Monti P.M., Pedraza M., Abrams D.B. Relevance of cue reactivity to understanding alcohol and smoking relapse. Journal of Abnormal Psychology 1988, 97:133-152.
40. O'Brien C.P., Childress A.R., Ehrman R., Robbins S.J. Conditioning factors in drug abuse: Can they explain compulsion?. Journal of Psychopharmacology 1998, 12(1):15-22.
41. Office of Applied Studies Results from the 2009 National Survey on Drug Use and Health: Volume II. Technical Appendices and Selected Prevalence Tables 2010, Substance Abuse and Mental Health Services Administration, Rockville, MD, (NSDUH series H-38B, HHS publication No. SMA 10-4856 Appendices).
42. Powell J., Gray J.A., Bradley B.P., Kasvikis Y., Strang J., Barratt L., et al. The effects of exposure to drug-related cues in detoxified opiate addicts: A theoretical review and some new data. Addictive Behaviors 1990, 15:339-354.
43. Reynolds E.K., Monti P.M. The cue reactivity paradigm in addiction research. Paper presented at the The Wiley-Blackwell Handbook of Addiction Psychopharmacology 2012.
44. Saladin M.E., Gray K.M., Carpenter M.J., LaRowe S.D., DeSantis S.M., Upadhyaya H.P. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. American Journal of Addictions 2012, 21:210-220.
45. Schacht J.P., Anton R.F., Myrick H. Functional neuroimaging studies of alcohol cue reactivity: A quantitative meta-analysis and systematic review. Addiction Biology 2013, 18:121-133.
46. Schlauch R.C., Gwynn-Shapiro D., Stasiewicz P.R., Molnar D.S., Lang A.R. Affect and craving: Positive and negative affect are differentially associated with approach and avoidance inclinations. Addictive Behaviors 2013, 38:1970-1979.
47. See R.E. Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacology Biochemistry and Behavior 2002, 71(3):517-529.
48. Sell L.A., Morris J.S., Bearn J., Frackowiak R.S.J., Friston K.J., Dolan R.J. Neural responses associated with cue evoked emotional states and heroin in opiate addicts. Drug and Alcohol Dependence 2000, 60(2):207-216.
49. Sheehan D.V., Lecrubier Y., Sheehan H., Amorim P., Janavs J., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59:22-33.
50. Shi J., Jun W., Zhao L.Y., Xue Y.X., Zhang X.Y., Kosten T.R., et al. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts. European Journal of Pharmacology 2009, 615:108-112.
51. Shiffman S., Dunbar M.S., Kirchner T.R., Li X., Tindle H.A., Anderson S.J., et al. Cue reactivity in non-daily smokers: Effects on craving and on smoking behavior. Psychopharmacology 2013, 226:321-333.
52. Siegel S. Drug anticipation and drug addiction. The 1998H. David Archibald lecture. Addiction 1999, 94(8):1113-1124.
53. Siegel S., Ramos B. Applying laboratory research: Drug anticipation and the treatment of drug addiction. Experimental and Clinical Psychopharmacology 2002, 10(3):162.
54. Sinha R. Modeling stress and drug craving in the laboratory: Implications for addiction treatment development. Addiction Biology 2009, 14(1):84-98.
55. Sinha R., Fuse T., Aubin L.R., O'Malley S.S. Psychology stress, drug-related cues and cocaine craving. Psychopharmacology 2000, 152:140-148.
56. Spielberger C.D. Manual for the State-Trait Anxiety Inventory STAI (Form Y) 1983, Mind Garden, Inc., Palo Alto, CA.
57. Stewart J. Stress and relapse to drug seeking: Studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability. The American Journal on Addictions 2003, 12(1):1-17.
58. Stewart J., DeWit H., Eieklboom R. The role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychological Review 1984, 91:51-268.
59. Substance Abuse and Mental Health Services Administration (SAMHSA) The TEDS report: Substance abuse treatment admissions involving abuse of pain relievers: 1998 and 2008 2010, Office of Applied Studies, Rockville, MD.
60. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2010 National Survey on Drug Use and Health. Summary of National Findings. NSDUH Series H-41 2011, Vol. I. Substance Abuse and Mental Health Services Administration, Rockville, MD.
61. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2011 National Survey on Drug Use and Health: Summary of national findings 2012, Department of Health and Human Services, Rockville, MD.
62. Tkacz J., Severt J., Cacciola J., Ruetsch C. Compliance with buprenorphine medication-assisted treatment and relapse to opioid use. The American Journal on Addictions 2012, 21(1):55-62.
63. Veilleux J.C., Colvin P.J., Anderson J., York C., Heinz A.J. A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review 2010, 30:155-166.
64. Warner M., Chen L.H., Makuc D.M., Anderson R.N., Miniño A.M. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief 2011, 81:1-8.
65. Weiss R.D., Potter J.S., Fiellin D.A., Byrne M., Connery H.S., Dickinson W., et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 2011, 66(12):1238-1246.
66. Yu J., Zhang S., Epstein D.H., Fang Y., Shi J., Qin H., et al. Gender and stimulus difference in cue-induced responses in abstinent heroin users. Pharmacology Biochemistry and Behavior 2007, 86:485-492.
67. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence 2003, 69:215-232.